NCT04446351
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04446351
Title Study of the Safety and Effectiveness of GSK6097608 in Participants With Advanced Solid Tumors
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors GlaxoSmithKline
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | CAN

Facility Status City State Zip Country Details
GSK Investigational Site Los Angeles California 90025 United States Details
GSK Investigational Site Boston Massachusetts 02215 United States Details
GSK Investigational Site Dallas Texas 75230 United States Details
GSK Investigational Site Houston Texas 77030-4009 United States Details
GSK Investigational Site San Antonio Texas 78229 United States Details
GSK Investigational Site Ottawa Ontario K1H 8L6 Canada Details
GSK Investigational Site Toronto Ontario M5G 1Z5 Canada Details
GSK Investigational Site Chiba 277-8577 Japan Details
GSK Investigational Site Tokyo 104-0045 Japan Details
GSK Investigational Site Seoul 03080 South Korea Details
GSK Investigational Site Seoul 06351 South Korea Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field